This content is machine translated Non-small cell lung cancer Management of locally advanced NSCLC – where are we heading? Lung cancer is the second most common and deadliest type of cancer worldwide. Clinically, non-small cell lung cancer (NSCLC) is the most common pathologic form of lung cancer; approximately one-third…
View Post 5 min This content is machine translated Lung cancer Perioperative therapy for better efficacy Neoadjuvant or adjuvant immunotherapy can improve outcomes in patients with resectable non-small cell lung cancer (NSCLC). It has now been observed that perioperative therapies can combine the benefits of both…
View Post 8 min This content is machine translated Lung cancer An overview of non-small cell lung cancer across all stages The European Lung Cancer Congress is a joint project of major multidisciplinary societies representing thoracic oncology specialists working together to advance science, disseminate education and improve the practice of lung…
View Post 3 min This content is machine translated Pneumooncology Optimal treatment of non-small cell lung cancer The treatment management of non-small cell lung cancer has improved significantly in recent years. Innovative treatment options point the way to personalized therapy with fewer side effects and an improved…
View Post 6 min This content is machine translated Non-small cell lung cancer Risk-adapted screening and treatment management Non-small cell lung carcinomas are the most common malignant tumors of the lung. 70–80% of all lung tumors can be assigned to this histology. A distinction can now be made…
View Post 7 min This content is machine translated Lung cancer Current research results for optimized management The European Lung Cancer Congress brings together key multidisciplinary societies to advance science, disseminate education and improve the practice of lung cancer specialists worldwide. At this year’s event, attendees were…
View Post 10 min This content is machine translated Chemo in hospice? Systems therapies for metastatic NSCLC in poor general health Non-small cell lung cancer (NSCLC) is the cancer with the highest mortality worldwide, with two-thirds of cases detected only at locally advanced or metastatic stages. Unfortunately, recommendations for patients with… CME-Test
View Post 10 min This content is machine translated Chemo in hospice? Systems therapies for metastatic NSCLC in poor general health. Non-small cell lung cancer (NSCLC) is the cancer with the highest mortality worldwide, with two-thirds of cases detected only at locally advanced or metastatic stages. Unfortunately, recommendations for patients with… CME-Test
View Post 3 min This content is machine translated Non-small cell lung cancer Platelets to predict immunotherapy response? Immunotherapy using checkpoint inhibitors has become an indispensable part of the treatment of non-small cell lung cancer. Nevertheless, there is room for improvement – and potential – in the area…
View Post 4 min This content is machine translated Non-small cell lung cancer Molecular diagnostics under the microscope To date, molecular testing in non-small cell lung cancer (NSCLC) has been reserved primarily for stage IV patients. However, with the introduction of targeted therapies also in earlier tumor stages,…
View Post 10 min This content is machine translated Chemo in hospice? Systems therapies for metastatic NSCLC in poor general health. Non-small cell lung cancer (NSCLC) is the cancer with the highest mortality worldwide, with two-thirds of cases detected only at locally advanced or metastatic stages. Unfortunately, recommendations for patients with… CME-Test
